[Source: Research & Innovation] For patients with rare genetic mutations of the debilitating disease cystic fibrosis, there are few options for effective treatment. EU-funded researchers are working to meet their needs, using new developments in personalised medicine to advance the testing of novel and promising drugs.
from EUROPA - Syndicated Research News Feed https://ift.tt/2I10nVb
via IFTTT
No comments:
Post a Comment